Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens: 'Attractive'
Tweet Send to a Friend
Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $31.00 price target on Bicara Therapeutics Inc (NASDAQ: BCAX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
